Prolonged use of dexmedetomidine in an infant with respiratory failure following living donor liver transplantation

Paediatric Anaesthesia

Volumn 16, Issue 12, 2006, Pages 1285-1288

  Enomoto, Yuki ^a   Kudo, Toyoichiro ^a   Saito, Takashi ^a   Hori, Tetsuo ^a   Kaneko, Michio ^a   Matsui, Akira ^a   Mizutani, Taro ^a,b  

^a UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Dexmedetomidine; Infant; Living donor liver transplantation; Mechanical ventilation; Prolonged use; Sedation

Indexed keywords

DEXMEDETOMIDINE; FENTANYL; GANCICLOVIR; KETAMINE; MIDAZOLAM; VECURONIUM;

ANAMNESIS; ANESTHESIA INDUCTION; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CHOLANGITIS; DRUG DOSE REDUCTION; DRUG USE; HEPATITIS; HUMAN; HUMAN TISSUE; INFANT; INFUSION RATE; LABORATORY TEST; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEDATION;

ANESTHESIA; DEXMEDETOMIDINE; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; INTENSIVE CARE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; TIME FACTORS;

EID: 33751033802     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2006.02008.x     Document Type: Article

References (13)

1. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000; 59: 263-268.
2. Coughlan MG, Lee JG, Bosnjak ZJ et al. Direct coronary and cerebral vascular responses to dexmedetomidine. Significance of endogenous nitric oxide synthesis. Anesthesiology 1992; 77: 998-1006.
3. Shehabi Y, Ruettimann U, Adamson H et al. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med 2004; 30: 2188-2196.
4. Multz AS. Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal. Anesth Analg 2003; 96: 1054-1055.
5. Tobias JD, Berkenbosch JW. Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J 2004; 97: 451-455.
6. Tobias JD, Berkenbosch JW, Russo P. Additional experience with dexmedetomidine in pediatric patients. South Med J 2003; 96: 871-875.
7. Tobias JD. Sedation and analgesia in the pediatric intensive care unit. Pediatr Ann 2005; 34: 636-645.
8. Hammer GB, Philip BM, Schroeder AR et al. Prolonged infusion of dexmedetomidine for sedation following tracheal resection. Pediatr Anesth 2005; 15: 616-620.
9. Bloor BC, Ward DS, Belleville JP et al. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992; 77: 1134-1142.
10. Hayashi Y, Maze M. Alpha 2 adrenoceptor agonists and anaesthesia. Br J Anaesth 1993; 71: 108-118.
11. Dyck JB, Maze M, Haack C et al. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993; 78: 813-820.
12. Venn M, Newman J, Grounds M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med 2003; 29: 201-207.
13. Davies MF, Haimor F, Lighthall G et al. Dexmedetomidine fails to cause hyperalgesia after cessation of chronic administration. Anesth Analg 2003; 96: 195-200.